Search

Ming Xin Wang

from Vestal, NY
Age ~48
Get Report
Also known as:
Ming X Wang, Mingxin Wang, Ming Wand
Related to:
Rachel X WangXiong Wang Kong, 50Hong Wang, 42Qiang Wang, 60Xiaoshuang Wang, 41De S WangYafang Wang, 44Juan WangFang Wang, 69Deying Zheng, 48
Connected to:
Aaron Wang, 36Aijie Wang, 54Ailin Y Wang, 67Aiying Wang, 63Alex F Wang, 51Alexandra Wang, 50Alfred C Wang, 47Ally H Wang, 50Amerfil M Wang, 80Andreas Wang, 28

Ming Wang Phones & Addresses

  • Vestal, NY
  • 11 Martha St, Binghamton, NY 13903
  • Flemington, NJ
  • Philadelphia, PA
  • Owego, NY
  • South El Monte, CA
  • Horseheads, NY

Professional Records

Medicine Doctors

Ming Wang Photo 1

Ming X. Wang

View page
Specialties:
Ophthalmology
Work:
Wang Vision Institute
1801 W End Ave STE 1150, Nashville, TN 37203
(615) 321-8881 (phone), (615) 321-8874 (fax)
Education:
Medical School
Harvard Medical School
Graduated: 1991
Procedures:
Corneal Surgery
Lens and Cataract Procedures
Ophthalmological Exam
Conditions:
Cataract
Keratitis
Acute Conjunctivitis
Diabetic Retinopathy
Glaucoma
Languages:
English
Spanish
Description:
Dr. Wang graduated from the Harvard Medical School in 1991. He works in Nashville, TN and specializes in Ophthalmology.
Ming Wang Photo 2

Ming L. Wang

View page
Specialties:
General Surgery, Traumatic Surgery
Work:
University Of New Mexico Hospital-Surgical Specialties Clinic
2211 Lomas Blvd NE FL 2, Albuquerque, NM 87106
(505) 272-3771 (phone), (505) 272-2330 (fax)
Education:
Medical School
Stony Brook University School of Medicine
Graduated: 2006
Procedures:
Proctosigmoidoscopy
Spleen Surgey
Thoracoscopy
Hernia Repair
Small Bowel Resection
Languages:
English
Spanish
Vietnamese
Description:
Dr. Wang graduated from the Stony Brook University School of Medicine in 2006. She works in Albuquerque, NM and specializes in General Surgery and Traumatic Surgery. Dr. Wang is affiliated with University Of New Mexico Hospital.
Ming Wang Photo 3

Ming H. Wang

View page
Description:
Dr. Wang graduated from the Tufts University School of Medicine in 1999. She works in Lutherville-Timonium, MD and 1 other location and specializes in Pediatric Urology. Dr. Wang is affiliated with The Johns Hopkins Hospital.
Ming Wang Photo 4

Ming Li Wang

View page
Specialties:
Surgery
Critical Care Medicine
Ming Wang Photo 5

Ming Rung Wang

View page
Specialties:
Anesthesiology
Education:
American University Of The Caribbean School Of Medicine (1988)
Ming Wang Photo 6

Ming Xu Wang

View page
Specialties:
Ophthalmology
Education:
Harvard University(1991)

License Records

Ming Rung Wang Md

License #:
2451 - Expired
Category:
Medicine
Issued Date:
Jul 1, 1989
Effective Date:
Jul 2, 1993
Type:
Temporary Educational Permit

Business Records

Name / Title
Company / Classification
Phones & Addresses
Ming Wang
Office Manager
Wang MD
Medical Doctor's Office
1 Clyde Rd, East Millstone, NJ 08873
49 Veronica Ave, East Millstone, NJ 08873
Ming Wang
Principal
Xiao Cui Chen
Nonclassifiable Establishments
135 Main St, Hackettstown, NJ 07840

Publications

Wikipedia

Jathan Albaladejo

View page

…made the Yankees' major league roster to start the 2009 season. After posting an earned run average of 6.00 in 18 appearances through May 22, he was optioned back down to Triple-A Scranton/Wilkes-Barre to make room on the roster for pitcher Chien-Ming Wang.[3] In 17 innings at Triple-A he co...

Us Patents

Inhibitors Of Histone Deacetylase Useful For The Treatment Or Prevention Of Hiv Infection

View page
US Patent:
20210403479, Dec 30, 2021
Filed:
Nov 4, 2019
Appl. No.:
17/288626
Inventors:
- Rahway NJ, US
Joseph Kozlowski - Princeton NJ, US
Dane James Clausen - Rahway NJ, US
Jian Liu - Edison NJ, US
Younong Yu - East Brunswick NJ, US
Ming Wang - Belle Mead NJ, US
Bing Li - Towaco NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07D 487/10
C07D 403/12
C07D 413/14
C07D 401/14
C07D 401/12
C07D 471/04
C07D 417/14
C07D 498/10
C07D 405/14
A61K 45/06
Abstract:
The present invention relates to Compounds of Formula I: and pharmaceutically acceptable salts or prodrug thereof, wherein R, R, R, Rand A are as defined herein. The present invention also relates to compositions comprising at least one compound of Formula I, and methods of using the compounds of Formula I for treating or preventing HIV infection in a subject.

Isoquinoline Derivatives As Mgat2 Inhibitors

View page
US Patent:
20180009796, Jan 11, 2018
Filed:
Jan 20, 2015
Appl. No.:
15/104537
Inventors:
- Rahway NJ, US
Timothy A. Blizzard - Princeton NJ, US
Brian T. Campbell - Burlington NJ, US
Helen Y. Chen - Marlboro NJ, US
John S. Debenham - Scotch Plains NJ, US
Sunita V. Dewnani - Secaucus NJ, US
Byron Dubois - New York NY, US
Candido Gude - Staten Island NY, US
Zack Zhiqiang Guo - Morganville NJ, US
Bart Harper - New York NY, US
Zhiyong Hu - Livingston NJ, US
Songnian Lin - Holmdel NJ, US
Ping Liu - Westfield NJ, US
Ming Wang - Belle Mead NJ, US
Feroze Ujjainwalla - Hoboken NJ, US
Jiayi Xu - Marlboro NJ, US
Libo Xu - Bridgewater NJ, US
Rui Zhang - Plainsboro NJ, US
International Classification:
C07D 413/14
C07D 417/14
C07D 413/12
C07D 471/04
C07D 401/12
Abstract:
The compounds of Formula I act as MGAT2 inhibitors and can be useful in preventing, treating or acting as a remedial agent for hyperlipidemia, diabetes mellitus and obesity.

Substituted Pyrimidines As Inhibitors Of Hif Prolyl Hydroxylase

View page
US Patent:
20170247336, Aug 31, 2017
Filed:
Oct 8, 2015
Appl. No.:
15/517557
Inventors:
- RAHWAY NJ, US
JOHN QIANG TAN - PRINCETON NJ, US
QUN DANG - WESTFIELD NJ, US
CHRISTOPHER J. SINZ - MIDDLETOWN NJ, US
ALEJANDRO CRESPO - EDISON NJ, US
MING WANG - BELLE MEAD NJ, US
YILI CHEN - HILLSBOROUGH NJ, US
JIAQIANG CAI - SHANGHAI, CN
FAN WU - SHANGHAI, CN
XIAOXING DU - SHANGHAI, CN
Assignee:
MERCK SHARP & DOHME CORP. - RAHWAY NJ
International Classification:
C07D 239/36
C07D 401/12
C07D 405/12
C07D 403/12
Abstract:
The present invention concerns compounds of Formula I that inhibit HIF prolyl hydroxylase, their use for enhancing endogenous production of erythropoietin, and for treating conditions associated with reduced endogenous production of erythropoietin such as anemia and like conditions, as well as pharmaceutical compositions comprising such a compound and a pharmaceutical carrier.

Pyrimidone Carboxamide Compounds As Pde2 Inhibitors

View page
US Patent:
20170015633, Jan 19, 2017
Filed:
Dec 17, 2014
Appl. No.:
15/107233
Inventors:
- Rahway NJ, US
- Shanghai, CN
Richard Berger - Harleysville PA, US
XiaoXia Qian - New York NY, US
Yimin Qian - Plainsboro NJ, US
Bart Harper - New York NY, US
Meng Yang - Westfield NJ, US
Zack Zhi Qiang Guo - Morganville NJ, US
Vanessa L. Rada - Hatfield PA, US
Deping Wang - Furlong PA, US
Timothy A. Cernak - Boston MA, US
Christopher Sinz - Middletown NJ, US
Ming Wang - Belle Mead NJ, US
Jonathan E. Wilson - South Orange NJ, US
Shimin Xu - Beijing, CN
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
MSD R & D (China) Co. LTD. - Shanghai NJ
International Classification:
C07D 239/36
C07D 401/12
C07D 403/04
C07D 403/06
C07D 487/04
C07D 403/14
C07D 405/12
C07D 405/14
C07D 413/04
C07D 417/04
C07D 401/06
C07D 403/12
Abstract:
Disclosed are pyrimidine carboxamide compounds of formula (I) which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 2 (PDE2), pharmaceutical compositions and uses thereof.

Inhibitors Of The Renal Outer Medullary Potassium Channel

View page
US Patent:
20160207922, Jul 21, 2016
Filed:
Jul 28, 2014
Appl. No.:
14/908222
Inventors:
- Rahway NJ, US
Barbara Pio - West Orange NJ, US
Jinlong Jiang - Scotch Plains NJ, US
Alexander Pasternak - Princeton NJ, US
Shuzhi Dong - Plainsboro NJ, US
Zack Zhiqiang Guo - Morganville NJ, US
Harry Chobanian - Aberdeen NJ, US
Jessica Frie - Harleysville PA, US
Yan Guo - Westfield NJ, US
Zhicai Wu - Montvale NJ, US
Yang Yu - Edison NJ, US
Ming Wang - Belle Mead NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07D 471/10
A61K 45/06
A61K 31/435
A61K 31/506
A61K 31/5386
C07D 451/00
A61K 31/46
A61K 31/497
C07D 498/10
A61K 31/444
A61K 31/501
Abstract:
The present invention provides compounds of Formula Iand the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.

Isbn (Books And Publications)

A Call to the Church from Wang Ming-Dao

View page
Author

Ming Dao Wang

ISBN #

0875080944

Reliability Analysis in Engineering Applications

View page
Author

Ming Wang

ISBN #

0442008422

Literacy, Narrative and Culture

View page
Author

Ming Wang

ISBN #

0700714979

Sage: Current Technologies And Applications

View page
Author

Ming Wang

ISBN #

1904933076

Control profile
Ming Xin Wang from Vestal, NY, age ~48 Get Report